The outlook revision acknowledges Doylestown’s marked rebound in liquidity and improved operating performance following unexpected losses during the first half of fiscal year 2016.
Moody’s also assigned a “Baa2” rating to Doylestown’s proposed $45 million of series 2016A bonds, $18.8 million of series 2016B bonds and $11.7 million of series 2016C bonds.
The rating assignment reflects Doylestown’s strong market position and proactive management team.
More articles on healthcare finance:
4 best practices for managing patient billing complaints
20 financial benchmarks for hospital executives
Quality Improvement Organizations resume two-midnight reviews
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
